Stock Track | LifeStance Health Soars 14.43% in Pre-Market on Strong Q4 Earnings Beat and $100M Share Buyback

Stock Track

Feb 25

LifeStance Health Group, Inc. shares surged 14.43% in pre-market trading following the release of its fourth quarter and full-year 2025 financial results, which exceeded analyst expectations and were accompanied by the announcement of a significant capital return program.

The mental healthcare provider reported Q4 revenue of $382.2 million, a 17% year-over-year increase that beat the IBES estimate of $376.3 million. Adjusted EBITDA for the quarter was $48.8 million, significantly surpassing the $40.3 million estimate, driven by higher visit volumes and improved operating leverage. The company also reported net income of $11.7 million for the quarter.

Further bolstering investor sentiment, LifeStance's Board of Directors approved a $100 million share repurchase program, reflecting confidence in the company's strong cash generation and healthy balance sheet. The company also provided optimistic guidance for 2026, expecting full-year revenue in the range of $1.615 billion to $1.655 billion and Adjusted EBITDA of $185 million to $205 million.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1198785583"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1198785583\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1198785583?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-25 19:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198785583","market":"sg","top_or_hot":-1,"title":"Stock Track | LifeStance Health Soars 14.43% in Pre-Market on Strong Q4 Earnings Beat and $100M Share Buyback","media":"Stock Track","content":"<p>LifeStance Health Group, Inc. shares surged 14.43% in pre-market trading following the release of its fourth quarter and full-year 2025 financial results, which exceeded analyst expectations and were accompanied by the announcement of a significant capital return program.</p><p>The mental healthcare provider reported Q4 revenue of $382.2 million, a 17% year-over-year increase that beat the IBES estimate of $376.3 million. Adjusted EBITDA for the quarter was $48.8 million, significantly surpassing the $40.3 million estimate, driven by higher visit volumes and improved operating leverage. The company also reported net income of $11.7 million for the quarter.</p><p>Further bolstering investor sentiment, LifeStance's Board of Directors approved a $100 million share repurchase program, reflecting confidence in the company's strong cash generation and healthy balance sheet. The company also provided optimistic guidance for 2026, expecting full-year revenue in the range of $1.615 billion to $1.655 billion and Adjusted EBITDA of $185 million to $205 million.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | LifeStance Health Soars 14.43% in Pre-Market on Strong Q4 Earnings Beat and $100M Share Buyback</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | LifeStance Health Soars 14.43% in Pre-Market on Strong Q4 Earnings Beat and $100M Share Buyback\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-02-25 19:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>LifeStance Health Group, Inc. shares surged 14.43% in pre-market trading following the release of its fourth quarter and full-year 2025 financial results, which exceeded analyst expectations and were accompanied by the announcement of a significant capital return program.</p><p>The mental healthcare provider reported Q4 revenue of $382.2 million, a 17% year-over-year increase that beat the IBES estimate of $376.3 million. Adjusted EBITDA for the quarter was $48.8 million, significantly surpassing the $40.3 million estimate, driven by higher visit volumes and improved operating leverage. The company also reported net income of $11.7 million for the quarter.</p><p>Further bolstering investor sentiment, LifeStance's Board of Directors approved a $100 million share repurchase program, reflecting confidence in the company's strong cash generation and healthy balance sheet. The company also provided optimistic guidance for 2026, expecting full-year revenue in the range of $1.615 billion to $1.655 billion and Adjusted EBITDA of $185 million to $205 million.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LFST","symbol_name":"LifeStance Health Group, Inc.","start_time":0,"source_url":"","article_id":"1198785583","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198785583","pubTimestamp":1772018925,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"LifeStance Health Group, Inc. shares surged 14.43% in pre-market trading following the release of its fourth quarter and full-year 2025 financial results, which exceeded analyst expectations and were...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LFST":"LifeStance Health Group, Inc."},"translate_title":"股票追踪|LifeStance Health盘前飙升14.43%，因第四季度盈利强劲增长和1亿美元股票回购","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LFST":1},"content_text":"LifeStance Health Group, Inc. shares surged 14.43% in pre-market trading following the release of its fourth quarter and full-year 2025 financial results, which exceeded analyst expectations and were accompanied by the announcement of a significant capital return program.The mental healthcare provider reported Q4 revenue of $382.2 million, a 17% year-over-year increase that beat the IBES estimate of $376.3 million. Adjusted EBITDA for the quarter was $48.8 million, significantly surpassing the $40.3 million estimate, driven by higher visit volumes and improved operating leverage. The company also reported net income of $11.7 million for the quarter.Further bolstering investor sentiment, LifeStance's Board of Directors approved a $100 million share repurchase program, reflecting confidence in the company's strong cash generation and healthy balance sheet. The company also provided optimistic guidance for 2026, expecting full-year revenue in the range of $1.615 billion to $1.655 billion and Adjusted EBITDA of $185 million to $205 million.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}